Related by context. All words. (Click for frequent words.) 82 Patients Treated With 81 Prolongs Survival 81 Previously Treated 81 Improves Survival 81 Antitumor Activity 80 Improves Outcomes 80 Advanced Melanoma 80 Meets Primary Endpoint 80 Inhaled Corticosteroids 79 Elderly Patients 79 Patients Receiving 79 Demonstrated Significant 79 Advanced Prostate Cancer 79 Patients Treated 79 Appears Safe 78 Improved Survival 78 Phase 2b Clinical Trial 78 Study Evaluating 78 Relapsed Refractory 78 Newly Diagnosed Multiple Myeloma 78 Well Tolerated 78 HER2 Positive Breast Cancer 78 Relapsing Multiple Sclerosis 78 Clinical Trial Evaluating 78 Resistant Hypertension 78 Patients Undergoing 78 Adjunctive Therapy 78 Improve Survival 78 Drug Candidate 78 Study Showed 78 Treated Patients 78 Oral Fingolimod 78 Long Term Efficacy 78 Survival Benefit 77 Phase IIb Trial 77 Shows Efficacy 77 Lowers Risk 77 Combination Therapy 77 Patients Suffering 77 Monotherapy 77 Statistically Significant 77 Adjuvant Treatment 77 Significantly Reduced 77 Disease Progression 77 Hormone Refractory Prostate Cancer 77 Previously Untreated 77 Drug Shows Promise 77 Relapsed Multiple Myeloma 77 Combination Treatment 77 Knee Osteoarthritis 77 Metastatic Colorectal Cancer 77 Lung Cancer Trial 77 Metastatic Prostate Cancer 76 Proves Effective 76 Novel Oral 76 Unfractionated Heparin 76 Epoetin Alfa 76 Significantly Improves 76 Phase 2b Study 76 Myeloma Patients 76 Phase 2b Trial 76 Severe Sepsis 76 Node Positive 76 Preclinical Data 76 Single Dose 76 Fracture Risk 76 Slow Progression 76 Anti Tumor Activity 76 Pooled Analysis 76 Complicated Skin 76 Treatment Experienced 76 Phase IIa Clinical Trial 76 Reduces Risk 76 FDA Okays 76 Investigational Treatment 76 Increases Risk 76 Efficacious 76 Phase III Clinical Trial 76 Castration Resistant Prostate Cancer 75 Phase 2a Clinical Trial 75 Breast Cancer Recurrence 75 Advanced Colorectal Cancer 75 Versus Placebo 75 Treatment Reduces 75 Chemoradiation 75 ACE Inhibitors 75 Adjuvant Therapy 75 Advanced Ovarian Cancer 75 Trial Evaluating 75 Chronic Hepatitis C 75 Rheumatoid Arthritis Patients 75 Fewer Side Effects 75 Study Demonstrates 75 Shows Promise Against 75 Combo Therapy 75 Demonstrates Significant 75 Secondary Hyperparathyroidism 75 Vaginal Gel 75 Demonstrates Potent 75 Demonstrates Efficacy 75 Mouse Model 75 Adjuvant Chemotherapy 75 FDA Approvals 75 Investigational Agent 75 Plus Ribavirin 75 Hormone Receptor Positive 75 Relapsing Remitting Multiple Sclerosis 75 Lung Cancer Survival 75 Significantly Reduces 75 Prostate Cancer Patients 75 Successfully Treated 75 Levels Linked 75 Bosutinib 75 Renal Cell Carcinoma 75 Artery Disease 75 Initiate Clinical Trial 75 II Clinical Trial 75 Myelodysplastic Syndromes 75 Diabetic Patients 75 Shows Promising 75 Cardiovascular Events 75 Demonstrates Positive 75 Protease Inhibitor 75 Phase 2a Trial 75 Advanced Renal Cell 74 Renal Impairment 74 Phase III Trial 74 Brain Metastases 74 Dose Escalation 74 Prove Effective 74 Anticancer Activity 74 Fungal Infections 74 Hypertensive Patients 74 Rotavirus Vaccine 74 Chronic Sinusitis 74 Blood Pressure Drug 74 Treatment Regimen 74 Phase IIb Clinical Trial 74 Insulin Glargine 74 Obesity Linked 74 NICE Recommends 74 Bone Metastases 74 Drug Combo 74 Significantly Improved 74 Statin Therapy 74 Refractory Hodgkin Lymphoma 74 HER2 Positive 74 Epilepsy Drug 74 Pediatric Patients 74 Anthracycline 74 Protein Linked 74 Peginterferon 74 Cholesterol Lowering Drug 74 Soft Tissue Sarcoma 74 Obese Patients 74 Bare Metal Stents 74 Treatment Naive Patients 74 Anti Tumor 74 Treating Chronic 74 Data Suggest 74 Partial Onset Seizures 74 Postmenopausal Osteoporosis 74 Overactive Bladder 74 Treatment Shows Promise 74 Nebulized 74 Teva Provides Update 74 Therapy Reduces 74 Lung Cancer Patients 74 Phase III Trials 74 Heart Failure Patients 74 FDA Approves Drug 74 HCV Protease Inhibitor 74 Hepatitis C Genotype 73 Receives Orphan Drug Designation 73 Fondaparinux 73 Beta Blockers 73 Subgroup Analysis 73 Generic Version 73 Clinical Trial Results 73 Pulmonary Arterial Hypertension 73 Non Responders 73 Reduces Pain 73 Metastatic Renal Cell Carcinoma 73 Androgen Deprivation Therapy 73 Dose Finding 73 Sustained Reduction 73 Premenopausal Women 73 Therapy Improves 73 Gene Variant 73 Pivotal Phase 73 Ischemic Stroke 73 Chronic Renal Failure 73 Tumor Growth 73 Lupus Drug 73 Mylan Receives Approval 73 Mg Usa 73 Diuretic 73 Pharmacokinetic Study 73 Colorectal Cancer Patients 73 Investigational Compound 73 Gene Linked 73 Combination REOLYSIN R 73 Completes Enrollment 73 Genes Linked 73 Metastatic Pancreatic Cancer 73 Slows Progression 73 Antidepressants Linked 73 Neoadjuvant Chemotherapy 73 Guidelines Issued 73 Poorly Controlled 73 Treatment Naïve 73 Contrast Agents 73 Beneficial Effects 73 Tyrosine Kinase Inhibitor 73 FDA APPROVES 73 Study Shows Promise 73 Vaccine Adjuvant 73 First Patient Dosed 73 Osteoporosis Drugs 73 Improve Outcomes 73 Fixed Dose 73 Peginterferon Alfa 2a 73 Transdermal Patch 73 Cell Transplants 73 Critically Ill Patients 73 Submits NDA 73 Nicotine Vaccine 73 Reduced Risk 73 Low Dose 73 Achieves Primary Endpoint 73 Osteoporosis Drug 73 Chronic Hepatitis B 73 Effectively Treats 73 Novel Compound 73 Fluticasone 73 Advanced Pancreatic Cancer 73 Acute Ischemic Stroke 73 Reduces Mortality 73 Carboplatin Paclitaxel 72 Gout Drug 72 ST Elevation Myocardial 72 Protease Inhibitors 72 Prospective Randomized 72 Infected Patients 72 Bone Marrow Cells 72 Tiotropium 72 Orally Active 72 Mg Uk 72 Metastatic Melanoma 72 Higher Doses 72 Phase III Pivotal Trial 72 Shows Promise 72 Gene Mutation 72 Oral Formulation 72 Files IND 72 Medoxomil 72 Sustained Efficacy 72 Liver Injury 72 TNF Blockers 72 Completes Patient Enrollment 72 Boosts Survival 72 Autologous Stem Cell Transplantation 72 Bronchodilator 72 Abdominal Pain 72 Present Preclinical Data 72 Disease Modifying 72 Experimental Vaccine 72 Placebo Controlled Study 72 FDA Clears 72 Confirmatory Phase 72 Pharmacokinetics PK 72 Tolerability 72 Proven Effective 72 Less Invasive 72 Oral Cladribine 72 Statin Drugs 72 Hypercholesterolemia 72 Increased Risk 72 Malignant Glioma 72 Inhaled Nitric Oxide 72 Effective Than 72 Asthma Symptoms 72 Prostate Cancer Vaccine 72 Cutaneous T 72 Blood Pressure Drugs 72 Treating Heart Failure 72 NDA Submission 72 Blood Thinner 72 Migraine Headaches 72 Diabetic Neuropathy 72 Left Ventricular Hypertrophy 72 Kidney Transplant Patients 72 Clot Busting 72 See CLINICAL PHARMACOLOGY 72 Patient Enrollment 72 PRN FDA Approves 72 Skeletal Muscle 72 Plaque Psoriasis 72 Hsp# Inhibitor 72 Long Term Survival 72 Cholesterol Levels 72 Cholesterol Drug 72 Minimally Invasive Treatment 72 Sulfonylurea 72 Liver Failure 72 Hemoglobin Levels 72 Drug Prevents 72 Recombinant Human 72 Vitamin D Linked 72 Zoledronic Acid 72 Osteoporosis Treatment 72 Improves Quality 72 Demonstrates Potential 72 Multiple Myeloma Patients 72 Brain Atrophy 72 Showed Significant 72 Receptor Agonist 72 Cardiovascular Outcomes 71 Novel Treatments 71 Kidney Function 71 Cholesterol Drugs 71 Benign Prostatic Hyperplasia 71 Osteoarthritis Patients 71 Test Detects 71 Controlled Trial 71 Pegylated Interferon 71 Treat Heart Failure 71 Investigational Drug 71 Efficacy Trial 71 Long Term Outcomes 71 Primary Hypercholesterolemia 71 Predict Risk 71 Antiplatelet 71 Stem Cell Treatment 71 Lung Cancer Risk 71 Arthritis Drug 71 Randomized Phase 71 Initiates Clinical Trial 71 Posaconazole 71 Phase 1b Clinical Trial 71 Initiate Phase 71 Calcium Supplements 71 Anticoagulant 71 Hepatitis C Patients 71 Prophylactic Treatment 71 Drug Resistant 71 Interferon Beta 71 Pegylated Liposomal Doxorubicin 71 Renal Cancer 71 Antiviral Activity 71 Commonly Prescribed 71 Desvenlafaxine Succinate 71 Cilostazol 71 Lowers Blood Pressure 71 Randomized Double Blind 71 Endometrial Cancer 71 Randomized Trials 71 TO AVOID PREGNANCY WHILE 71 Novel Mechanism 71 Study Shows Benefits 71 Double Blind Randomized 71 Immune Responses 71 Allergic Asthma 71 Induction Therapy 71 Pivotal Study 71 Confirms Efficacy 71 Blood Clot Risk 71 Generic Versions 71 Virus Infection 71 Chronic Constipation 71 IND Application 71 Fast Track Status 71 Renal Function 71 Extended Release 71 Drug Fails 71 Intravenous Formulation 71 Chemotherapy Improves 71 Glatiramer Acetate 71 Diabetic Nephropathy 71 Pivotal Phase III 71 Unstable Angina 71 Bipolar Depression 71 Parathyroid Hormone 71 Commonly Used 71 CYP#A# CYP#D# 71 Presents Preclinical Data 71 Demonstrates Statistically Significant 71 Ovarian Cancer Patients 71 Antitumor 71 Interferon beta 1a 71 Preterm Delivery 71 Symptom Relief 71 Bone Fractures 71 Clinical Study Shows 71 Genes Predict 71 Bivalirudin 71 Increased Mortality 71 Rheumatoid Arthritis Drug 71 Postmenopausal Women 71 Zorbtive TM 71 Naive Patients 71 Kinase Inhibitor 71 Localized Prostate Cancer 71 Eases Pain 71 Preclinical Study 71 Invasive Fungal Infections 71 Beta Blocker 71 Demonstrate Significant 71 Antifungal 71 Breast Cancer Treatment 71 Clinical Outcome 71 Cyclooxygenase 2 71 Aggressive Prostate Cancer 71 First Patient Enrolled 71 Serious Infections 71 Immunomedics Announces 71 Intracerebral Hemorrhage 71 Inhibits 71 Gastric Cancer 71 Relapsed Refractory Multiple Myeloma 71 Newly Diagnosed 71 Thromboembolism 71 Cholesterol Lowering 71 Phospholipase A2 71 Heartburn Drugs 71 Initiates Clinical Trials 71 Sirolimus Eluting 71 Adjunctive 71 JAK Inhibitor 70 Orthostatic Hypotension 70 alfa 2a 70 Stent Implantation 70 Nucleoside 70 Bipolar Mania 70 Premature Infants 70 Blood Clots 70 Advanced Solid Tumors 70 Viral Load 70 Glucose Control 70 Treatment Naive HIV 70 Adefovir 70 Insulin Sensitivity 70 Montelukast 70 Randomized Controlled Trials 70 Prolongs Life 70 Spinal Fusion 70 Allogeneic 70 Human Monoclonal Antibody 70 Lung Cancer Drug 70 Hospital Acquired Pneumonia 70 Inhaled Steroids 70 Meta Analysis 70 Helps Prevent 70 Spectrum Pharmaceuticals Announces 70 Invasive Breast Cancer 70 Pregnancy Linked 70 Antidepressant Use 70 Pulmonary Artery 70 Hemodialysis Patients 70 Recurrent Ovarian Cancer 70 Melphalan 70 Allergic Rhinitis 70 Clinical Efficacy 70 Patients Enrolled 70 Migraine Treatment 70 Sevelamer 70 Unresectable 70 Induces 70 Dose Ranging Study 70 Antiplatelet Therapy 70 Venous Thromboembolism 70 IN PATIENTS WITH 70 Therapy Shows Promise 70 Receptor Antagonist 70 Strongly Linked 70 Schizophrenia Drug 70 Treat Anemia 70 Breast Cancers 70 FDA Panel Recommends 70 Radiofrequency Ablation 70 Cancer Recurrence 70 Severe Psoriasis 70 Visceral Fat 70 Antipsychotic Drugs 70 Testosterone Patch 70 Colorectal Adenomas 70 Carotid Stenting 70 Often Misdiagnosed 70 Hormone Therapy 70 Novel Antibiotic 70 Bosentan 70 Granted Orphan Drug 70 R Saizen R 70 Expanded Indication 70 Physical Function 70 Muscle Wasting 70 Cyclophosphamide 70 SPRYCEL ® 70 Cognitive Decline 70 Capecitabine 70 Randomized Study 70 Therapeutic Efficacy 70 Gene Variation 70 Antipsychotic Medications 70 Lung Tumors 70 Investigational Oral 70 Malignant Melanoma 70 Randomized Clinical Trials 70 Acute Migraine 70 Being Studied 70 Study Evaluates 70 Smoking Linked 70 Oral Mucositis 70 Estrogen Therapy 70 Coronary Arteries 70 Receives Positive Opinion 70 MEK Inhibitor 70 Chronic Bronchitis 70 Vildagliptin 70 Septic Shock 70 AnaSpec Introduces 70 Psoriasis Drug 70 Study Indicates 70 Transplant Patients 70 Electrical Stimulation 70 Left Ventricular 70 Presents Positive 70 Treatment Naïve Patients 70 Study Casts Doubt 70 Erectile Dysfunction Drug 70 ® lenalidomide 70 brand ciclesonide HFA 70 Controlled Study 70 Treatment Naive 70 Prevent Stroke 70 Stem Cell Transplants 70 Significant Improvement 70 Hydrochloride Injection 70 Antipsychotic Drug 70 Node Negative 70 Antiviral Drugs 70 Anti TNF 70 Aurora Kinase 70 Colorectal Cancer Risk 70 Lower Blood Pressure 70 Tablet Formulation 70 Viral Infection 70 Severe Asthma 70 FDA Warns Against 70 Lipid Lowering 70 Endothelial Cells 70 Complete Remission 70 Radiation Dose 70 Clinically Proven 70 Gastric Ulcers 70 Topical Treatment 70 Radical Prostatectomy 70 Tipranavir 70 Lupus Nephritis 70 Mayo Clinic Study Finds 70 Demonstrates Superior 70 Milestone Payment 70 Virus Linked 70 Cocaine Addiction 69 Chronic Heart Failure 69 Anti Clotting Drug 69 Significant Reduction 69 Hyperlipidemia 69 Juvenile Idiopathic Arthritis 69 Diet Linked 69 Sirolimus Eluting Stent 69 Potentially Fatal 69 Significant Improvements 69 Double Blind Placebo 69 Epilepsy Drugs 69 Successfully Treats 69 TNF Tumor Necrosis Factor 69 Immunomodulatory 69 Glucose Levels 69 Antibiotic Use 69 Proton Pump Inhibitors 69 Schizophrenia Treatment 69 Hip Fractures 69 Predict Dementia 69 Breast Cancer Patients 69 Risedronate 69 Fludarabine 69 Impairs 69 Tumor Response 69 Bone Mineral Density 69 Newly Diagnosed Patients 69 CDC Recommends 69 Acetate Rectal Suppositories 69 Novel Inhibitor 69 Renal Insufficiency 69 Preclinical Models 69 Vaccine Prevents 69 Ischemic 69 Treatment Resistant 69 Mycophenolate Mofetil 69 Genetic Tests 69 Enlarged Prostate 69 Corticosteroid 69 Generalized Anxiety Disorder 69 Allergic Reactions 69 Capsules CII 69 Seasonal Allergic Rhinitis 69 Diabetic Foot Ulcer 69 ST Segment Elevation 69 Sleep Disturbances 69 Lenalidomide 69 Blood Vessels 69 Prostate Cancer Progression 69 Migraine Drug 69 Urinary Tract Infections 69 Initiate Phase III 69 Dasatinib 69 Iron Overload 69 Topline Results 69 Follicular Lymphoma 69 benzoic acid hyoscyamine sulfate 69 Shown Effective 69 Epidermal Growth Factor Receptor 69 Tigecycline 69 Help Diagnose 69 Bone Fracture 69 Genes Identified 69 Fibromyalgia Pain 69 Chronic Cough 69 Demonstrates Sustained 69 Glufosfamide 69 Intrathecal 69 Efficacy Results 69 Randomized Clinical Trial 69 Helps Relieve 69 Taxane 69 Novel Compounds 69 Drug Coated Stents 69 Immune Cells 69 Blood Pressure Lowering 69 Paraplatin ® 69 Meet Primary Endpoint 69 Randomized Phase II 69 Pre Cancerous 69 bone marrow reticulin deposition 69 Atypical Hemolytic Uremic Syndrome 69 Chemotherapy Regimen 69 Peptic Ulcer 69 Interferon Gamma 69 Chemotherapy Induced 69 Combination Vaccine 69 Anemia Drug 69 Immunosuppressant 69 FDA Approves 69 Oral Anticoagulant 69 PROCTOCORT R 69 Who Underwent 69 Pain Relievers 69 Platelet Inhibition 69 Shingles Vaccine 69 Liver Metastases 69 Acute Exacerbations 69 Eur J 69 Dementia Patients 69 Prostate Biopsy 69 ACE Inhibitor 69 Cardiogenic Shock 69 Aflibercept 69 Antipsychotic 69 Acute Myocardial Infarction 69 Could Prevent 69 Progenitor Cells 69 Sapacitabine 69 Viral Suppression 69 Asthma Treatment 69 Endovascular Treatment 69 Successfully Completes Phase 69 Menopausal Women 69 Doctors Warn 69 Glycemic Control 69 Kidney Transplants 69 Endothelial Function 69 Dialysis Patients 69 Therapeutic Potential 69 Anti Inflammatory Drug 69 Renal Cell Cancer 69 Begins Dosing 69 Genetic Variant 69 Neoadjuvant 69 oral antidiabetic medication 69 Vaccine Candidate 69 Kidney Transplant Recipients 69 Moderate Drinking 69 Bloodstream Infections 69 Decitabine 69 Initiates Enrollment 69 Skin Lesions 69 Dendritic Cells 69 Holds Promise 69 ORLive Presents 69 Adverse Effects 69 Tumor Cell 69 Dual Antiplatelet Therapy 69 Liver Damage 69 Chronic HCV 69 Cardiac Resynchronization 69 achieved CCyR 69 Atomoxetine 69 ergot derivatives 69 Thiazolidinediones 69 R Bortezomib 69 Thyroid Hormone 69 unfractionated heparin UFH 69 Uric Acid 69 Cardiotoxicity 69 Contrast Agent 69 Helps Predict 69 Pemetrexed 69 Prostate Tumors 69 Prognostic Value 69 Randomized Placebo Controlled Trial 69 Phase Ib Clinical Trial 69 Breast Tumors 69 R lenalidomide 69 Elevated Levels 69 Device Helps 69 Non Inferiority 69 Pivotal Trial 69 Abortion Pill 69 Clinically Significant 68 Valsartan 68 Tezampanel 68 Commence Phase 68 Develop Novel 68 Stent Placement 68 moderate hepatic impairment 68 Combination Clinical Trial 68 Pegylated 68 Replacement Therapy 68 Stomach Cancer 68 Adalimumab 68 Guidelines Recommend 68 Pivotal Trials 68 Oral Contraceptives 68 Pegloticase 68 JAK2 Inhibitor 68 Testosterone Gel 68 Initiates Phase III 68 Sandostatin R 68 Crit Rev 68 Drug Combinations 68 Irinotecan 68 Nilotinib 68 Cognitive Function 68 Inhalation Aerosol 68 Diabetic Neuropathic Pain 68 Topical Cream 68 Zileuton 68 Adenoma 68 Tegretol carbamazepine 68 Antidepressant Drug 68 Bevacizumab 68 Severe Acne 68 Monoclonal Antibody 68 Gastrointestinal Stromal Tumors 68 Study Reinforces 68 Leukemia Cells 68 Oral Calcitonin 68 Abciximab 68 Novel Therapeutic 68 8mg/kg 68 Gene Variants 68 Telaprevir VX 68 Hepatocellular Carcinoma 68 Lung Injury 68 Fulvestrant 68 Brain Scans 68 Hepatitis B Vaccine 68 Migraine Headache 68 Iron Deficiency 68 Study Compares 68 Initiates Phase 68 Initiates Phase II 68 Recurrent Breast Cancer 68 Vertebral Fractures 68 FDA Accepts 68 Universal Flu Vaccine 68 Postherpetic Neuralgia 68 Thrombotic 68 nortriptyline Pamelor 68 Intra Arterial 68 Atypical Antipsychotic 68 Glucocorticoid 68 moderate renal impairment 68 Chronic Myeloid Leukemia 68 Modulates 68 Hemolysis 68 Venous Thrombosis 68 Attenuates 68 Potent Inhibitor 68 Danazol 68 See CONTRAINDICATIONS 68 Predict Response 68 adalimumab Humira 68 Aspirin Reduces 68 Mitral Regurgitation 68 Unstable Angina Non 68 Acute Pancreatitis 68 Study Proves 68 ACTEMRA TM 68 Correlation Between 68 Hepatic Encephalopathy 68 Lung Function 68 Inflammatory Response 68 Survival Rates 68 Prostatic 68 Lymphocytic 68 PEGylated Fab fragment 68 Depressive Symptoms 68 Low Density Lipoprotein Cholesterol 68 Prognostic Significance 68 Ventricular Arrhythmias 68 Vaccine Shows Promise 68 FUSILEV enhances 68 Testosterone Levels 68 Diffuse Large B 68 Shows Statistically Significant 68 Lowering Blood Pressure 68 First Patient Treated 68 Inflammatory Markers 68 ODT metoclopramide HCl PEPCID 68 Gene Mutation Linked 68 Gene Mutations 68 Exacerbation 68 Weight Loss Drug 68 Predict Prostate Cancer 68 Osteoarthritis Pain 68 Clinical Trial Data 68 Receives Approvable Letter 68 Suppresses 68 diclofenac Voltaren 68 Fluorouracil 68 Ovarian Cancer Risk 68 Anti Inflammatory 68 Calcium Vitamin D 68 Alternative Treatments 68 RNAi Therapeutic 68 Gum Disease 68 Seasonal Allergies 68 Safinamide 68 Recurrent Glioblastoma 68 Systemic Sclerosis 68 Dose Response 68 Stent Restenosis 68 Renal Anemia 68 Initiates Clinical 68 Mouse Models 68 Cardiovascular Disease Risk 68 Hepatocellular 68 Randomized Double blind 68 mild renal insufficiency 68 Inadequately Controlled 68 Effective Treatments 68 Leukemias 68 J Am Coll 68 Betaferon R 68 Paclitaxel Carboplatin 68 Announces FDA Clearance 68 Multicenter Trial 68 Hedgehog Pathway 68 Aliskiren 68 COPEGUS R 68 Ziprasidone 68 nicardipine 68 Carbidopa Levodopa 68 Oral Contraceptive 68 Angiotensin Converting Enzyme 68 topical gel formulation 68 essential thrombocythemia ET 68 Brentuximab Vedotin SGN 68 Reduced Incidence 68 Study Confirms 68 myelodysplastic myeloproliferative diseases 68 Parenteral Nutrition 68 Breathing Problems 68 Pneumonia Vaccine 68 Non Invasive Treatment 68 Synta Announces 68 Lowers Cholesterol 68 Epratuzumab 68 Genital Warts 68 Myocardial Perfusion Imaging 68 Ecallantide 68 Panic Disorder 68 Respiratory Distress 68 Enoxaparin 68 Epileptic Seizures 68 Cell Lymphoma 68 nizatidine 68 Recurrent Stroke 68 Signaling Pathway 68 Kidney Tumors 68 J Shoulder Elbow 68 Solid Tumors 68 Polymerase Inhibitor 68 Pneumococcal Vaccine 68 Cancer Treatments 68 Weight Loss Pill 68 Blood Thinning 68 Cognitive Impairment 68 Acute Attacks 68 Arthritis Sufferers 68 Pivotal Clinical Trial 68 Idiopathic Pulmonary Fibrosis 68 Genes Associated 68 Breast Cancer Cells 68 Maleate 68 Potent Anti 68 COPD Exacerbations 68 CLINICAL STUDIES 68 IIa Clinical Trial 68 Asthma COPD 68 Male Contraceptive 68 Factor Receptor 68 MR Angiography 67 Moxifloxacin 67 Genes Involved 67 ORENCIA ® 67 Regimens 67 Newly Diagnosed Breast Cancer 67 Angiogenic 67 Liver Tumors 67 Bone Marrow Transplants 67 Hepatitis C Treatment 67 Kidney Failure 67 Primary Endpoint 67 Intravitreal 67 STELARA TM 67 Lipid Levels 67 Relapsed 67 Generic Version Of 67 ARIXTRA R 67 Renal Artery 67 dasatinib Sprycel ® 67 Lanthanum Carbonate 67 Portal Hypertension 67 Inhaled Insulin 67 Neuroprotective Effects 67 Detect Cancer 67 Golimumab 67 Natalizumab 67 Menstrual Cramps 67 Anticancer Drug 67 Immune Cell 67 Int J 67 Cholinesterase Inhibitors 67 Ranolazine 67 Urine Test 67 Nymox NX 67 Synthetic Peptide 67 ritonavir boosted 67 Anti CD# Antibody 67 Radiofrequency Ablation RFA 67 Vaccine Protects Against 67 Trastuzumab 67 Seasonal Influenza Vaccine 67 Widely Used 67 phenyl salicylate methylene blue 67 Post Operative 67 Obese Teens 67 Low Doses 67 Cancer Cells 67 Lubiprostone 67 Organ Rejection 67 Initiates Dosing 67 Percutaneous Tibial Nerve Stimulation 67 Myocardial Ischemia 67 Cerebrospinal Fluid 67 Protein Involved 67 Atopic Dermatitis 67 Antibiotic Treatment 67 Cancer Patients Treated 67 Basal Cell 67 Patient Enrolment 67 chronic eosinophilic leukemia 67 Cypher Sirolimus 67 Could Predict 67 Topical Gel 67 Robotic Assisted 67 Can Predict 67 Interferon Alpha 67 Rheumatoid 67 Vicriviroc 67 Indacaterol 67 Genetic Predisposition 67 Reduce Risk 67 Liver Toxicity 67 Menopausal Symptoms 67 Circulating Tumor Cells